These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22294531)

  • 41. Resource utilization in on- and off-pump coronary artery surgery: factors influencing postoperative length of stay--an experience of 1,746 consecutive patients undergoing fast-track cardiac anesthesia.
    Scott BH; Seifert FC; Grimson R; Glass PS
    J Cardiothorac Vasc Anesth; 2005 Feb; 19(1):26-31. PubMed ID: 15747265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
    Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP
    Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma sequestration: a good therapy to prevent the deleterious effect of clopidogrel when clopidogrel is used within one to four days of coronary bypass surgery.
    Schill DM
    Perfusion; 2010 Mar; 25(2):91-5. PubMed ID: 20427413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preoperative platelet inhibition with ASA does not influence postoperative blood loss following coronary artery bypass grafting.
    Gulbins H; Malkoc A; Ennker IC; Ennker J
    Thorac Cardiovasc Surg; 2009 Feb; 57(1):18-21. PubMed ID: 19169991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study.
    Gurbuz AT; Zia AA; Vuran AC; Cui H; Aytac A
    Eur J Cardiothorac Surg; 2006 Feb; 29(2):190-5. PubMed ID: 16388957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting.
    Kim DH; Daskalakis C; Silvestry SC; Sheth MP; Lee AN; Adams S; Hohmann S; Medvedev S; Whellan DJ
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1377-84. PubMed ID: 19931667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study.
    Øvrum E; Tangen G; Tølløfsrud S; Ringdal MA; Øystese R; Istad R
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):545-8. PubMed ID: 20067988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clopidogrel did not inhibit platelet function early after coronary bypass surgery: A prospective randomized trial.
    Lim E; Cornelissen J; Routledge T; Kirtland S; Charman SC; Bellm S; Munday H; Khan O; Masood I; Large S
    J Thorac Cardiovasc Surg; 2004 Sep; 128(3):432-5. PubMed ID: 15354104
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of clopidogrel on bleeding complications and survival in off-pump coronary artery bypass grafting.
    Bittner HB; Lehmann S; Rastan A; Mohr FW
    Interact Cardiovasc Thorac Surg; 2012 Mar; 14(3):273-7. PubMed ID: 22194278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
    Tetik S; Ak K; Isbir S; Eksioglu-Demiralp E; Arsan S; Iqbal O; Yardimci T
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):189-98. PubMed ID: 19703819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention.
    Hochholzer W; Trenk D; Frundi D; Blanke P; Fischer B; Andris K; Bestehorn HP; Büttner HJ; Neumann FJ
    Circulation; 2005 May; 111(20):2560-4. PubMed ID: 15809367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study.
    Velik-Salchner C; Maier S; Innerhofer P; Streif W; Klingler A; Kolbitsch C; Fries D
    Anesth Analg; 2008 Dec; 107(6):1798-806. PubMed ID: 19020120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study.
    Angiolillo DJ; Bernardo E; Palazuelos J; Desai B; Weisberg I; Alfonso F; Guzman LA; Hernández-Antolin R; Zenni MZ; Macaya C; Fernandez-Ortiz A; Bass TA
    Thromb Haemost; 2008 Jan; 99(1):161-8. PubMed ID: 18217149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting.
    Chen L; Bracey AW; Radovancevic R; Cooper JR; Collard CD; Vaughn WK; Nussmeier NA
    J Thorac Cardiovasc Surg; 2004 Sep; 128(3):425-31. PubMed ID: 15354103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding.
    Tanaka KA; Szlam F; Kelly AB; Vega JD; Levy JH
    Platelets; 2004 Aug; 15(5):325-32. PubMed ID: 15370104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients.
    David JL; Limet R
    Thromb Haemost; 1999 Nov; 82(5):1417-21. PubMed ID: 10595630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of clopidogrel (Plavix) in patients undergoing nonelective orthopaedic surgery.
    Nydick JA; Farrell ED; Marcantonio AJ; Hume EL; Marburger R; Ostrum RF
    J Orthop Trauma; 2010 Jun; 24(6):383-6. PubMed ID: 20502223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. General thoracic surgery is safe in patients taking clopidogrel (Plavix).
    Cerfolio RJ; Minnich DJ; Bryant AS
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):970-6. PubMed ID: 20804992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bleeding-associated outcomes with preoperative clopidogrel use in on- and off-pump coronary artery bypass.
    Berger JS; Herout PM; Harshaw Q; Steinhubl SR; Frye CB; Becker RC
    J Thromb Thrombolysis; 2012 Jul; 34(1):56-64. PubMed ID: 22350624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
    Patti G; Pasceri V; Vizzi V; Ricottini E; Di Sciascio G
    Am J Cardiol; 2011 Apr; 107(7):995-1000. PubMed ID: 21256470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.